Skip to content

Clinical Dementia Rating Medical Record

Reliability of the Clinical Dementia Rating Scale From the Medical Record in Comparison With the Reference Method.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04763941
Acronym
CLIMER
Enrollment
144
Registered
2021-02-21
Start date
2020-01-01
Completion date
2022-12-31
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Dementia Rating (CDR) Face-to-face Interview With the Patient, Clinical Dementia Rating (CDR) From the Analysis of Medical Record

Keywords

CDR, memory consultation, patient's file, reliability

Brief summary

The assessment of severity of the cognitive and functional impairment is essential in the follow-up of patients with neurocognitive disorders and in the assessment of the effectiveness of therapeutics. However, the systematic assessment of the Clinical Dementia Rating (CDR) scale is limited due to the time required to complete it (approximately 45 min to 1 hour). Insofar as studies have shown correspondences between the CDR and scales measuring cognitive and neuropsychological performance, and as part of memory consultations, several functional and neuropsychological scales are systematically administered, we wish to conduct a study validating the feasibility of the CDR based on information already available in the patient's file compared to the evaluation of the CDR by the usual method (face-to-face interview in consultation). This study should highlight the feasibility of scoring the CDR-SB from the files of patients in memory consultation, first in terms of reliability of the scores obtained compared to the standard evaluation, and on the other hand in terms of organization and duration of administration.

Interventions

DIAGNOSTIC_TESTCDR assessment face-to-face

The assessment of the CDR is administered once by a psychologist with the patient and his caregiver.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient who has CDR assessment in face-to-face interview during the memory consultation, * Patient with an isolated cognitive complaint or a neurocognitive disorder * Patient included in the MEMORA cohort

Exclusion criteria

* Patient or caregiver who does not wish their data to be used for research purposes within the framework of the MEMORA cohort.

Design outcomes

Primary

MeasureTime frameDescription
CDR Sum of boxes (CDR-SB) score out of 18The CDR-SB score is collected at the baseline.The CDR-SB score is obtained in normal condition and on file for the same patients. The CDR-SB score makes it possible to distinguish the following classes: 0 (normal), 0.5-4 (questionable cognitive impairment), 0.5-2.5 (questionable impairment), 3-4 (very mild major TNC or very mild dementia), 4.5- 9 (mild or mild dementia), 9.5-15.5 (moderate dementia), 16-18 (severe dementia). The patient's aptitudes are assessed in 6 different areas: 3 cognitive skills: memory, orientation and judgment, 3 acts of everyday living: participation in collective life, home occupations and hobbies, personal care.

Countries

France

Contacts

Primary ContactAnthony Bathsavanis, Psy D
anthony.bathsavanis@chu-lyon.fr4 72 432 206
Backup ContactVirginie Dauphinot
virginie.dauphinot@chu-lyon.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026